ChronoScale Corporation Common Stock (NASDAQ:CHRN) versus TSS (NASDAQ:TSSI) Head-To-Head Analysis

ChronoScale Corporation Common Stock (NASDAQ:CHRN) and TSS (NASDAQ:TSSI) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Profitability

This table compares ChronoScale Corporation Common Stock and TSS’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
ChronoScale Corporation Common Stock	-135.66%	-66.16%	-18.14%
TSS	8.45%	21.40%	10.09%

Insider & Institutional Ownership

6.4% of ChronoScale Corporation Common Stock shares are held by institutional investors. 0.3% of ChronoScale Corporation Common Stock shares are held by company insiders. Comparatively, 16.0% of TSS shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Recommendations

This is a breakdown of recent ratings and target prices for ChronoScale Corporation Common Stock and TSS, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ChronoScale Corporation Common Stock	1	1	2	0	2.25
TSS	0	2	1	0	2.33

ChronoScale Corporation Common Stock currently has a consensus target price of $21.00, indicating a potential upside of 82.29%. TSS has a consensus target price of $12.00, indicating a potential upside of 74.17%. Given ChronoScale Corporation Common Stock’s higher probable upside, analysts clearly believe ChronoScale Corporation Common Stock is more favorable than TSS.

Valuation and Earnings

This table compares ChronoScale Corporation Common Stock and TSS”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ChronoScale Corporation Common Stock	$12.80 million	131.08	-$50.32 million	($4.32)	-2.67
TSS	$201.45 million	0.97	$15.12 million	$0.58	11.88

TSS has higher revenue and earnings than ChronoScale Corporation Common Stock. ChronoScale Corporation Common Stock is trading at a lower price-to-earnings ratio than TSS, indicating that it is currently the more affordable of the two stocks.

Risk and Volatility

ChronoScale Corporation Common Stock has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, TSS has a beta of 2.06, suggesting that its share price is 106% more volatile than the S&P 500.

Summary

TSS beats ChronoScale Corporation Common Stock on 10 of the 14 factors compared between the two stocks.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.

About TSS

TSS, Inc. (NASDAQ:TSSI) provides data center infrastructure solutions and related services for organizations that require reliable, scalable computing environments. The company supports the planning, design, deployment, and operation of data center facilities and technology infrastructure. Its services may include data center engineering and construction support, equipment procurement and integration, installation, infrastructure management, and ongoing maintenance. TSS serves customers with demanding information technology requirements, including enterprises, technology companies, and data center operators.